<DOC>
	<DOCNO>NCT01553773</DOCNO>
	<brief_summary>The aim trial compare effect estradiol genistein treatment hialuronic acid concentration postmenopausal facial skin . In study , 30 postmenopausal woman evaluate prospective , randomize , double-blind trial . The volunteer postmenopausal woman treat Gynecology Department Federal University São Paulo ( UNIFESP ) . The participant divide two group : group E , treat 17 β estradiol gel 0.01 % ( n = 15 ) , group G , treat genistein gel 4 % ( isoflavones , n=15 ) . The length treatment 24 consecutive week . Preauricular skin biopsy perform patient treatment evaluate hyaluronic acid tissue . The material process immunohistochemical biochemical method .</brief_summary>
	<brief_title>Postmenopausal Facial Skin After Estradiol Genistein Topical Treatment</brief_title>
	<detailed_description>Postmenopausal volunteer recruit Brazil Endocrinological Gynecology Division Gynecology Department Federal University São Paulo ( UNIFESP ) . All woman participate prospective , randomize , double-blind estrogen-controlled study approve local Ethics Research Committee ( Report No 386/2004 ) . The evaluation subject consist detailed history , physical exam , laboratory workup . The study protocol approve UNIFESP School Medicine Human Investigation Committee , every participant provide write informed consent enrollment . Intervention Independent pharmacists dispense either isoflavone estrogen container accord computer-generated randomization list . The container , well jar treatment , identical appearance color . The researcher responsible see woman allocate next available number entry trial , woman collect container directly pharmacy department . The code reveal researcher recruitment , data collection , histological analysis complete . If health problem occur , independent physician blind patient 's treatment group examine . If necessary , physician prescribe laboratory exams exclusion serious systemic side-effects . A number two punch biopsy facial skin preauricular area perform 24-week gel treatment . The woman apply gel facial skin daily night , morning , use gel sunscreen . They advise use cream . To assess possible systemic hormonal effect , hormonal vaginal cytology sample take visit ( baseline 6 , 12 , 18 , 24 week treatment ) estradiol blood sample treatment . Groups The participant flow stage study . After end study , label open , treatment group number classify . Fifteen patient require study group : group E , treat gel 17-β estradiol 0.01 % ( n = 15 ) , group G , treat gel isoflavones ( genistein 4 % ) ( n = 15 ) . Processing material After collection , biopsy immediately fix 24 hour 10 % formaldehyde solution process paraffin via dehydration ethanol increase concentration , diaphanization xylol impregnation liquid paraffin dry oven set temperature 60 °C ( methodology recommend Michalany , 1998 ) . The paraffin block submit cut 3 μm Minot microtome . The cut immunohistochemistry place slide previously treat silane 5 % bring oven 37 °C 24 hour dry . Additionally , section make 20 μm place tube 2ml biochemical processing .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>two five year postmenopause ; FSH &gt; 40 mU/ml ; estrogen level &lt; 20 pg/ml ; body mass index ( BMI ) &lt; 30 kg/m2 treatment estrogen soybeans previous 12 month ; tobacco user ; woman contraindication hormone therapy , use retinoids herbal substance , history collagen disease . also , strict vegetarianism , high fiber high soydiet consumption ; regular consumption vitamin mineral supplementation great Recommended Dietary Allowances ; antibiotic treatment ; history chronic disorder , include endocrine gynecological disease neoplasia , well benign breast disease ; regular use medication know interfere study endpoint . patient cervicovaginal cytology classify Papanicolaou Class III also exclude . participant hypertension use two antihypertensive drug include study .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Hyaluroic acid</keyword>
	<keyword>Estradiol</keyword>
	<keyword>Isoflavone</keyword>
	<keyword>Skin</keyword>
	<keyword>Postmenopause</keyword>
</DOC>